February 15, 2010 Vol. XXVII, No. 7 Sign up for our FREE PW e-newsletter Home Past Issues Search Register Contact Us Back to Phys Weekly  Popular Articles  1. Managing COPD: An Update on GOLD Standards 2. Making the Case for Advanced Directives 3. Preventing MRSA Transmission  Making The Rounds   Clinical Update  Analyzing Disability Trends in Older Americans      A California research team has found that older Americans are becoming increasingly disabled as... Patient Perspectives on Healthcare      Hospital patient satisfaction appeared to reach a new peak in 2008, according to a new report...  Reading Room  Quality Data Standards Released for EHRs      The National Quality Forum has released a standard set of definitions for capturing quality data...  Through The Pipeline  A Rapid Test for Bacterial Contamination in Platelets      The FDA has cleared for marketing the first rapid test (Platelet PGD Test System, Verax... New Therapy Treats Menorrhagia      Tranexamic acid (Lysteda, Xanodyne Pharmaceuticals), a non-hormonal product, has been approved... This Week's Feature Story Strategies to Improve Medication Adherence      A diverse group of healthcare and consumer organizations have released recommendations to promote better adherence to medication use and improve health outcomes for patients. [ More ]  In The News  Depression & Chronic Opioid Use      Patients with a history of depression appear to be more likely to receive long-term opioid therapy for non-cancer pain than those without a history of depression. A study found that incident and prevalent long-term opioid use rates were three times higher in those with a history of depression. [ More ] Laser Therapy for Chronic Neck Pain      Low-level laser therapy (LLLT) appears to reduce pain immediately after treatment in acute neck pain and for up to 22 weeks after completion of treatment in patients with chronic neck pain, according to an analysis of 16 randomized trials involving 820 participants. In acute neck pain, results of two trials showed a relative risk (RR) of 1.69 for pain improvement of LLLT versus placebo. [ More ] Heart Disease Connected to Psychosis      Patients with psychosis appear to be more likely to die from heart disease than those without these mental health issues, according to a national study. After controlling for sociodemographic and clinical factors, the study group found that those with schizophrenia (hazard ratio, 1.25) or other psychotic disorders (hazard ratio, 1.41) were more likely to die from heart disease than those without mental disorders. [ More ]  In My Opinion...  Emerging Drug Options: Adolescent Depression GRAHAM J. EMSLIE, MD Chief of Adolescent Psychiatry UT-Southwestern and Children’s Medical Center of Dallas Professor of Psychiatry University of Texas-Southwestern Medical Center   To get Physician's Weekly posted in your hospital, click HERE PW Archives | Past Issues | Register | Contact Us | Search Archive | Back To Top © 2010 Physician’s Weekly, LLC Web design and development by Spindustry Interactive™

There is no survey at this time.